Table 1.
Characteristics of participants who completed 3-month follow-up
| Characteristics | Overall, n (%) | Participants, n (%) according to genomic risk group | ||
|---|---|---|---|---|
| Low-risk (n = 25) | Average-risk (n = 49) | High-risk (n = 29) | ||
| Age group | ||||
| 18–44 years | 28 (27) | 7 (28) | 12 (24) | 9 (31) |
| 45–69 years | 75 (73) | 18 (72) | 37 (76) | 20 (69) |
| Gender | ||||
| Female | 54 (52) | 15 (60) | 23 (47) | 16 (55) |
| Male | 49 (48) | 10 (40) | 26 (53) | 13 (45) |
| Education | ||||
| High school or equivalent | 22 (21) | 5 (20) | 12 (24) | 5 (17) |
| Certificate/diploma/university degree | 81 (79) | 20 (80) | 37 (76) | 24 (83) |
| Family history of melanoma | 30 (29) | 8 (32) | 14 (29) | 8 (28) |
| Personal or family history of cancer | 48 (47) | 8 (32) | 26 (53) | 14 (48) |
| Has children | 71 (69) | 18 (72) | 34 (69) | 19 (66) |